BHC

Bausch Health Companies Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth 9/10
  • Momentum 4/10
Bausch Health Companies sales and earnings growth
BHC Growth
Great
  • Revenue Y/Y 6.66%
  • EPS Y/Y 423.08%
  • FCF Y/Y -21.00%
Bausch Health Companies gross and profit margin trends
BHC Profitability
Good
  • Gross margin 70.70%
  • EPS margin 1.50%
  • ROIC 7.80%
Bausch Health Companies net debt vs free cash flow
BHC Risk
Poor
  • Debt / Equity 55.3
  • Debt / FCF 19.7
  • Interest coverage 1.3

Bausch Health Companies stock volatility is in-line with the overall market. We give it a Poor risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗